Theresa Sexton is a Managing Partner at Claritas Capital, where she sources and evaluates privately held. See portfolio, sector focus and contact routes.
Theresa Sexton is a Managing Partner at Claritas Capital, where she sources and evaluates privately held companies seeking late-stage venture and growth capital, having joined the firm in 2008. Her investment thesis targets healthcare, technology, and business services companies primarily located in the Southeast and Mid-Atlantic regions. The firm focuses on late-stage venture and growth capital rounds, though specific check sizes and lead versus follow behavior are not publicly detailed in available sources. Notable portfolio companies where she serves on the board include Kindbody, Genomind, Apcela, and Alchemy 43. Sexton also holds board positions at Marinalife, One of None (1/X), TwelveStone Health Partners, and Virtue Technologies. Prior to Claritas, she spent over 10 years at Massey Burch Capital Corp. handling investor services, fund administration, and transaction work. While she serves as board President for a local non-profit supporting at-risk families and incarcerated women, no distinctive public writing or unique investment point of view is documented in current sources.
StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Nashville.
Investors like Theresa Sexton · Full investor directory · Investor access · Company funding database